USC's first psychedelic trial pairs psilocybin with mindfulness meditation, asking whether contemplative training deepens the therapy's effects. It enrolls 72 adults and tracks EEG, fMRI, and biological markers before and after treatment. #Neuroscience https://bit.ly/4a7oWQa
